Warby Parker (WRBY) Competitors $26.35 -0.99 (-3.63%) Closing price 03:59 PM EasternExtended Trading$26.18 -0.16 (-0.61%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock WRBY vs. PEN, STVN, IRTC, GKOS, BLCO, TMDX, SLNO, NVST, LIVN, and INSPShould you be buying Warby Parker stock or one of its competitors? The main competitors of Warby Parker include Penumbra (PEN), Stevanato Group (STVN), iRhythm Technologies (IRTC), Glaukos (GKOS), Bausch + Lomb (BLCO), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Envista (NVST), LivaNova (LIVN), and Inspire Medical Systems (INSP). These companies are all part of the "medical equipment" industry. Warby Parker vs. Its Competitors Penumbra Stevanato Group iRhythm Technologies Glaukos Bausch + Lomb TransMedics Group Soleno Therapeutics Envista LivaNova Inspire Medical Systems Warby Parker (NYSE:WRBY) and Penumbra (NYSE:PEN) are both mid-cap medical equipment companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, profitability, valuation, risk, media sentiment, analyst recommendations and institutional ownership. Is WRBY or PEN more profitable? Penumbra has a net margin of 11.54% compared to Warby Parker's net margin of -1.12%. Penumbra's return on equity of 11.55% beat Warby Parker's return on equity.Company Net Margins Return on Equity Return on Assets Warby Parker-1.12% -0.79% -0.41% Penumbra 11.54%11.55%8.76% Which has preferable earnings and valuation, WRBY or PEN? Penumbra has higher revenue and earnings than Warby Parker. Warby Parker is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioWarby Parker$771.32M3.59-$20.39M-$0.07-376.39Penumbra$1.19B8.27$14.01M$3.7667.40 Which has more risk and volatility, WRBY or PEN? Warby Parker has a beta of 2.09, meaning that its share price is 109% more volatile than the S&P 500. Comparatively, Penumbra has a beta of 0.4, meaning that its share price is 60% less volatile than the S&P 500. Do analysts recommend WRBY or PEN? Warby Parker currently has a consensus price target of $24.06, indicating a potential downside of 8.67%. Penumbra has a consensus price target of $300.47, indicating a potential upside of 18.57%. Given Penumbra's stronger consensus rating and higher probable upside, analysts clearly believe Penumbra is more favorable than Warby Parker.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Warby Parker 0 Sell rating(s) 8 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.58Penumbra 0 Sell rating(s) 3 Hold rating(s) 13 Buy rating(s) 2 Strong Buy rating(s) 2.94 Do insiders & institutionals have more ownership in WRBY or PEN? 93.2% of Warby Parker shares are owned by institutional investors. Comparatively, 88.9% of Penumbra shares are owned by institutional investors. 18.2% of Warby Parker shares are owned by company insiders. Comparatively, 5.0% of Penumbra shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Does the media refer more to WRBY or PEN? In the previous week, Penumbra had 12 more articles in the media than Warby Parker. MarketBeat recorded 29 mentions for Penumbra and 17 mentions for Warby Parker. Penumbra's average media sentiment score of 1.06 beat Warby Parker's score of 0.91 indicating that Penumbra is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Warby Parker 10 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Penumbra 23 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryPenumbra beats Warby Parker on 14 of the 17 factors compared between the two stocks. Get Warby Parker News Delivered to You Automatically Sign up to receive the latest news and ratings for WRBY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding WRBY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart WRBY vs. The Competition Export to ExcelMetricWarby ParkerCONS PD IndustryStaples SectorNYSE ExchangeMarket Cap$2.77B$32.71B$16.12B$20.88BDividend YieldN/A2.60%3.10%3.59%P/E Ratio-376.3339.5317.9828.34Price / Sales3.592.0447.6154.38Price / Cash79.9216.4814.8817.82Price / Book7.868.616.104.54Net Income-$20.39M$1.23B$687.69M$992.74M7 Day Performance8.03%7.92%1.15%0.29%1 Month Performance10.15%6.93%19.66%1.13%1 Year Performance84.76%26.05%2.85%11.00% Warby Parker Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)WRBYWarby Parker2.2941 of 5 stars$26.35-3.6%$24.06-8.7%+89.0%$2.77B$771.32M-376.333,780PENPenumbra4.8215 of 5 stars$255.35+0.9%$300.47+17.7%+34.0%$9.87B$1.19B67.914,500Positive NewsSTVNStevanato GroupN/A€22.50-0.5%N/A+13.2%€6.81B€1.19B41.675,521Gap DownIRTCiRhythm Technologies1.3232 of 5 stars$157.93-1.7%$157.30-0.4%+141.2%$5.16B$591.84M-53.902,000News CoverageGKOSGlaukos4.7176 of 5 stars$89.47-0.4%$127.42+42.4%-29.8%$5.15B$383.48M-54.22780Positive NewsBLCOBausch + Lomb2.206 of 5 stars$14.49-0.4%$15.56+7.4%-9.5%$5.15B$4.79B-18.5713,500Positive NewsTMDXTransMedics Group2.7354 of 5 stars$125.65-1.5%$123.00-2.1%-26.2%$4.35B$441.54M65.10210Positive NewsSLNOSoleno Therapeutics4.6011 of 5 stars$68.09-4.9%$114.30+67.9%+40.6%$3.81BN/A-16.4530News CoverageAnalyst ForecastNVSTEnvista3.7635 of 5 stars$20.75+0.5%$20.92+0.9%+15.8%$3.43B$2.51B64.8312,300LIVNLivaNova2.5628 of 5 stars$53.27-0.8%$59.29+11.3%+15.7%$2.93B$1.25B-13.692,900INSPInspire Medical Systems4.9247 of 5 stars$88.28+0.6%$165.62+87.6%-53.2%$2.60B$802.80M51.031,246Positive NewsBuyback AnnouncementShort Interest ↓ Related Companies and Tools Related Companies PEN Competitors STVN Competitors IRTC Competitors GKOS Competitors BLCO Competitors TMDX Competitors SLNO Competitors NVST Competitors LIVN Competitors INSP Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:WRBY) was last updated on 8/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Warby Parker Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Warby Parker With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access